The effect of a monensin ruminal delivery device on performance of cattle grazing pasture.
A total of 28 trials utilizing 2,262 steers and heifers were conducted to evaluate a sustained monensin2 ruminal delivery device (RDD) on the daily gain of grazing cattle. Five series of trials, with four to eight trials per series within a grazing season, were conducted to evaluate the daily gain response under different environmental conditions and locations. Pastures grazed included both summer (cool- and warm-season grasses and native range) and winter (rye, ryegrass and wheat) growing pastures. The experimental design for all trials in each of five series was a randomized complete block with initial weight or breed as the blocking factor. The treatments compared in series I, III, IV and V (20 trials) were a control and a single RDD, whereas in series II (eight trials), a 2 x 2 factorial was utilized that compared RDD and estradiol 17-beta controlled release implants. In the five series of trials, the monensin RDD increased daily gain .04 (P = .002), .03 (P = .07), .09 (P = .01), .05 (P = .10) and .08 kg (P = .04) compared with the controls. Use of the RDD provided an effective method of achieving consistent monensin delivery and weight gain improvement without requiring the extra labor needed to administer monensin via hand-feeding or self-feeding supplements, blocks or loose mineral.
Lilly Research Laboratories, Greenfield, IN 46140.
J C
JC
Parrott
J M
JM
Conrad
R P
RP
Basson
L C
LC
Pendlum
D000821:Animal Feed; D000818:Animals; D002417:Cattle / Q000254:growth & development*; D003692:Delayed-Action Preparations; D005260:Female; D008297:Male; D008985:Monensin / Q000008:administration & dosage* / Q000494:pharmacology; D006109:Poaceae; D012417:Rumen; D012434:Secale; D015430:Weight Gain / Q000187:drug effects*
D003692:Delayed-Action Preparations; D008985:Monensin